Oxford Immunotec Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Oxford Immunotec (OXFD) Tops Q1 EPS by 10c, Revenues Beat
May 9, 2019 7:13 AM EDTOxford Immunotec (NASDAQ: OXFD) reported Q1 EPS of ($0.06), $0.10 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $13.82 million.
First quarter revenue of $14.8 million, an increase of 27% compared to prior year periodGross... More